These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 38607011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow.
    Dux M, Vogler B, Kuhn A, Mackenzie KD, Stratton J, Messlinger K.
    Cells; 2022 May 28; 11(11):. PubMed ID: 35681463
    [Abstract] [Full Text] [Related]

  • 3. The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats.
    Vogler B, Kuhn A, Mackenzie KD, Stratton J, Dux M, Messlinger K.
    Int J Mol Sci; 2023 Aug 30; 24(17):. PubMed ID: 37686275
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation.
    Ramachandran R, Bhatt DK, Ploug KB, Hay-Schmidt A, Jansen-Olesen I, Gupta S, Olesen J.
    Cephalalgia; 2014 Feb 30; 34(2):136-47. PubMed ID: 24000375
    [Abstract] [Full Text] [Related]

  • 6. Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab.
    Benedicter N, Messlinger K, Vogler B, Mackenzie KD, Stratton J, Friedrich N, Dux M.
    Neurol Int; 2023 Apr 29; 15(2):622-637. PubMed ID: 37218978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.
    Melo-Carrillo A, Noseda R, Nir RR, Schain AJ, Stratton J, Strassman AM, Burstein R.
    J Neurosci; 2017 Jul 26; 37(30):7149-7163. PubMed ID: 28642283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization.
    Capuano A, Greco MC, Navarra P, Tringali G.
    Eur J Pharmacol; 2014 Oct 05; 740():97-102. PubMed ID: 24998872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.
    Melo-Carrillo A, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, Burstein R.
    J Neurosci; 2017 Nov 01; 37(44):10587-10596. PubMed ID: 28972120
    [Abstract] [Full Text] [Related]

  • 16. Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat.
    Friedrich N, Németh K, Tanner M, Rosta J, Dobos I, Oszlács O, Jancsó G, Messlinger K, Dux M.
    J Headache Pain; 2024 Jan 19; 25(1):9. PubMed ID: 38243174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion.
    Feistel S, Albrecht S, Messlinger K.
    J Headache Pain; 2013 Nov 20; 14(1):93. PubMed ID: 24256609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.